📢 Update: this account will no longer be active.
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Carthera | LinkedIn
Carthera | 6,995 followers on LinkedIn. Advanced Brain Therapy | Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range o...
www.linkedin.com
October 2, 2025 at 12:22 PM
📢 Update: this account will no longer be active.
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
Thank you for following our journey here. Moving forward, we’ll continue to share all corporate and clinical news on our LinkedIn page 👉 www.linkedin.com/company/carthera/
We look forward to staying connected with you there!
We have joined BlueSky!
For those new to Carthera, we are a #medtech company developing the SonoCloud, an innovative implantable ultrasound device that can temporarily disrupt the blood-brain barrier with the aim to enhance drug-delivery to the brain transforming neurological care🧠
For those new to Carthera, we are a #medtech company developing the SonoCloud, an innovative implantable ultrasound device that can temporarily disrupt the blood-brain barrier with the aim to enhance drug-delivery to the brain transforming neurological care🧠
January 13, 2025 at 10:22 AM
We have joined BlueSky!
For those new to Carthera, we are a #medtech company developing the SonoCloud, an innovative implantable ultrasound device that can temporarily disrupt the blood-brain barrier with the aim to enhance drug-delivery to the brain transforming neurological care🧠
For those new to Carthera, we are a #medtech company developing the SonoCloud, an innovative implantable ultrasound device that can temporarily disrupt the blood-brain barrier with the aim to enhance drug-delivery to the brain transforming neurological care🧠
Very proud to be one of the Catalan awardees of the @erc.europa.eu Proof of Concept grants.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
February 6, 2026 at 9:01 AM
Very proud to be one of the Catalan awardees of the @erc.europa.eu Proof of Concept grants.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
The grant #SonoMYC is built on the collaboration among @vhio.bsky.social, #Peptomyc and #Carthera.
Grateful to the #ERC for supporting us and honoured to be in the company of extraordinary colleagues.
Our CSO was recently featured on the PsyDactic podcast!
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
Therapeutic Ultrasound with Dr. Michael Canney PhD - PsyDactic
This episode includes a fascinating interview with a researcher in ultrasound, Dr. Michael Canney who is an acoustics researcher the chief scientific officer at a French company named Carthera (https:...
psydactic.buzzsprout.com
June 13, 2025 at 7:53 AM
Our CSO was recently featured on the PsyDactic podcast!
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
📲 Want to gain insights into the future of ultrasound technology and the work being done at Carthera?
Listen to the full episode here: psydactic.buzzsprout.com/1909786/epis...
#Ultrasound #Research #Podcast
🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
September 9, 2025 at 3:35 PM
🗓️ Meet the Carthera team in October for the latest insights into our Phase III study evaluating SonoCloud‑9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19
💬 Drop by our booths or send us a DM to arrange a meeting
💬 Check out this Q&A with our CCO Carole Desseaux, CSO Michael Canney, and PI Adam Sonabend on the SONOBIRD trial, exploring therapeutic ultrasound for recurrent #glioblastoma - @fusfoundation.bsky.social
👉 www.fusfoundation.org/posts/therap...
👉 www.fusfoundation.org/posts/therap...
Therapeutic Ultrasound for Recurrent Glioblastoma: A Q&A on Carthera’s Comparative Clinical Trial
Key Points Almost a year ago in February 2024, Carthera launched its large comparative SonoCloud® Blood-Brain Barrier Opening for Recurrent Disease (SONOBIRD*) clinical trial (NCT 05902169) in Europe ...
www.fusfoundation.org
January 16, 2025 at 10:08 AM
💬 Check out this Q&A with our CCO Carole Desseaux, CSO Michael Canney, and PI Adam Sonabend on the SONOBIRD trial, exploring therapeutic ultrasound for recurrent #glioblastoma - @fusfoundation.bsky.social
👉 www.fusfoundation.org/posts/therap...
👉 www.fusfoundation.org/posts/therap...
Summer Review: Transforming Glioblastoma Treatment 🧠
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
August 28, 2025 at 11:37 AM
Summer Review: Transforming Glioblastoma Treatment 🧠
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
🙏 Thank you to our hardworking team, supportive partners, dedicated researchers and brave patients for supporting our mission of providing a new treatment for #glioblastoma
Interviews & Podcast access 👉 linktr.ee/carthera
🎧 LISTEN IN: Sound waves meet brain science.
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
May 29, 2025 at 7:01 AM
🎧 LISTEN IN: Sound waves meet brain science.
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
In this podcast, Carthera shares how we use ultrasound to tackle brain tumors and neurodegenerative diseases.
Learn about our SONOBIRD pivotal clinical trial; changing how we fight #glioblastoma 👉 sonobird.eu
podcasts.apple.com/us/podcast/e...
🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
September 24, 2025 at 12:33 PM
🗓️ Meet the Carthera team from next week for the latest insights into our Phase III study evaluating SonoCloud 9 for #glioblastoma
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
🇦🇹 #EANS2025 Vienna, 5-9 [Booth 8]
🇺🇸 #CNS2025 LA, 11-15 [Booth 588]
🇨🇿 #EANO2025 Prague, 16-19 [Booth 9]
💬 Drop by our booths or send us a DM to arrange a meeting
Finding a #braintumor clinical trial can be overwhelming.
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
Ancora - Find Cancer Clinical Trials
Ancora is a search tool that enables cancer patients to find relevant clinical trials in minutes. Radiopharmaceutical trial finder, nuclear medicine.
www.ancora.ai
September 18, 2025 at 12:06 PM
Finding a #braintumor clinical trial can be overwhelming.
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
That’s why Carthera is proud to sponsor Ancora.ai’s Brain Tumor Trial Finder — a tool that helps patients and families quickly navigate options and access clinical trials worldwide 🌍www.ancora.ai/en?condition...ai
Want to know more about our Sonobird trial? Check out this Q&A with our CCO Carole Desseaux, CSO Michael Canney, and PI Adam Sonabend on therapeutic ultrasound for recurrent #glioblastoma
👉 www.fusfoundation.org/posts/therap...
👉 www.fusfoundation.org/posts/therap...
Therapeutic Ultrasound for Recurrent Glioblastoma: A Q&A on Carthera’s Comparative Clinical Trial
Key Points Almost a year ago in February 2024, Carthera launched its large comparative SonoCloud® Blood-Brain Barrier Opening for Recurrent Disease (SONOBIRD*) clinical trial (NCT 05902169) in Europe ...
www.fusfoundation.org
February 11, 2025 at 10:26 AM
Want to know more about our Sonobird trial? Check out this Q&A with our CCO Carole Desseaux, CSO Michael Canney, and PI Adam Sonabend on therapeutic ultrasound for recurrent #glioblastoma
👉 www.fusfoundation.org/posts/therap...
👉 www.fusfoundation.org/posts/therap...
🗞 A team of our researchers and collaborators including Kwang-Soo Kim and Adam Sonabend from @nufeinbergmed.bsky.social and Dhan Chand from Agenus, in partnership with Carthera, published an article in Neuro-Oncology
Full study👇
academic.oup.com/neuro-oncolo...
#oncology #neurology #gliomas
Full study👇
academic.oup.com/neuro-oncolo...
#oncology #neurology #gliomas
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas
AbstractBackground. Glioblastoma is a highly aggressive brain cancer that is resistant to conventional immunotherapy strategies. Botensilimab, an Fc-enhanc
academic.oup.com
January 28, 2025 at 10:11 AM
🗞 A team of our researchers and collaborators including Kwang-Soo Kim and Adam Sonabend from @nufeinbergmed.bsky.social and Dhan Chand from Agenus, in partnership with Carthera, published an article in Neuro-Oncology
Full study👇
academic.oup.com/neuro-oncolo...
#oncology #neurology #gliomas
Full study👇
academic.oup.com/neuro-oncolo...
#oncology #neurology #gliomas
Carthera is proud to support #WorldCancerDay
This year's theme focuses on patient stories and today we would like to share Lynn's story📖
Lynn experienced tumor regrowth after standard treatments, which led her to taking part in our Sonobird trial.
Read her story👇
www.med.unc.edu/neurosurgery...
This year's theme focuses on patient stories and today we would like to share Lynn's story📖
Lynn experienced tumor regrowth after standard treatments, which led her to taking part in our Sonobird trial.
Read her story👇
www.med.unc.edu/neurosurgery...
Glioblastoma Patient Joins the Sonobird Clinical Trial at UNC Health | Department of Neurosurgery
Lynn lives an active lifestyle as an owner of her own luxury traveling tours business. But when she got back from a corporate cruise in November of 2023, she started to feel sick every day. Lynn was q...
www.med.unc.edu
February 4, 2025 at 9:16 AM
Carthera is proud to support #WorldCancerDay
This year's theme focuses on patient stories and today we would like to share Lynn's story📖
Lynn experienced tumor regrowth after standard treatments, which led her to taking part in our Sonobird trial.
Read her story👇
www.med.unc.edu/neurosurgery...
This year's theme focuses on patient stories and today we would like to share Lynn's story📖
Lynn experienced tumor regrowth after standard treatments, which led her to taking part in our Sonobird trial.
Read her story👇
www.med.unc.edu/neurosurgery...
Our latest podcast features Michael Canney, PhD, CSO at Carthera, discussing the company’s SonoCloud-9, an implantable ultrasound device that temporarily opens the blood-brain barrier to help chemotherapy reach glioblastoma (GBM) tumors more effectively.
https://ow.ly/gJj350XjRoi
https://ow.ly/gJj350XjRoi
October 30, 2025 at 2:02 PM
Our latest podcast features Michael Canney, PhD, CSO at Carthera, discussing the company’s SonoCloud-9, an implantable ultrasound device that temporarily opens the blood-brain barrier to help chemotherapy reach glioblastoma (GBM) tumors more effectively.
https://ow.ly/gJj350XjRoi
https://ow.ly/gJj350XjRoi
In this episode, Michael Canney, PhD, CSO at Carthera, discusses the company’s SonoCloud-9, an implantable therapeutic ultrasound device designed to temporarily open the blood-brain barrier and enable drugs to reach tumors like glioblastoma more effectively. https://ow.ly/Va1w50XfFgL
Ep40: Therapeutic Ultrasound for Glioblastoma: Carthera’s Comparative Clinical Trial | Curing with Sound
In this episode of Curing with Sound, we explore a groundbreaking approach to one of medicine’s toughest cancers, glioblastoma (GBM), with Michael Canney, PhD, Chief Scientific Officer at Carthera. GBM is the most aggressive form of brain cancer, notoriously hard to treat because the blood-brain barrier (BBB) blocks many life-saving drugs from reaching tumor cells. With survival rates of just one to two years, new approaches are urgently needed.
Dr. Canney shares how Carthera’s SonoCloud-9, an implantable, therapeutic ultrasound device, temporarily opens the BBB and enhances the delivery...
ow.ly
October 21, 2025 at 4:02 PM
In this episode, Michael Canney, PhD, CSO at Carthera, discusses the company’s SonoCloud-9, an implantable therapeutic ultrasound device designed to temporarily open the blood-brain barrier and enable drugs to reach tumors like glioblastoma more effectively. https://ow.ly/Va1w50XfFgL
Feed: "Newswise: Latest News"
By: Focused Ultrasound Foundation on Wednesday, November 5, 2025
By: Focused Ultrasound Foundation on Wednesday, November 5, 2025
Ep40: Therapeutic Ultrasound for Glioblastoma: Carthera's Comparative Clinical Trial
In this episode of Curing with Sound, we explore a groundbreaking approach to one of medicine’s toughest cancers, glioblastoma (GBM), with Michael Canney, PhD, Chief Scientific Officer at Carthera. GB...
www.newswise.com
November 5, 2025 at 9:15 AM
Feed: "Newswise: Latest News"
By: Focused Ultrasound Foundation on Wednesday, November 5, 2025
By: Focused Ultrasound Foundation on Wednesday, November 5, 2025
Feed: "Medical Device Network"
By: Ross Law on Tuesday, July 1, 2025
By: Ross Law on Tuesday, July 1, 2025
Carthera’s ultrasound system earns EMA endorsement as an orphan medical device
Carthera has received an orphan medical device status endorsement for its SonoCloud ultrasound system for treating brain disorders under a new pilot programme by the European Medicines Agency (EMA).
www.medicaldevice-network.com
July 2, 2025 at 12:36 PM
Feed: "Medical Device Network"
By: Ross Law on Tuesday, July 1, 2025
By: Ross Law on Tuesday, July 1, 2025
Our CSO was recently featured on The Childhood Cancer Perspective
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
S5:E78 Interview with Dr. Michael Canney
YouTube video by Battlecorn Care Packages
www.youtube.com
June 26, 2025 at 8:14 AM
Our CSO was recently featured on The Childhood Cancer Perspective
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
Tune in to learn more about our vision and the impactful work being done at Carthera www.youtube.com/watch?v=VsCq...
#BrainCancerResearch #Glioblastoma #MedicalBreakthroughs
This weekend, our Chief Scientific Officer spoke with @foxnews.com.web.brid.gy to break down what people should know about glioblastoma following Michael Bolton's diagnosis, and how Carthera is advancing progress toward new breakthroughs in treatment delivery.
Full article: bit.ly/42ZTdM9
Full article: bit.ly/42ZTdM9
Michael Bolton had strange symptoms before brain cancer diagnosis: ‘Something’s wrong’
A Grammy-winning singer who was diagnosed in December 2023 with glioblastoma—the most aggressive and rapidly progressing type of brain cancer—began showing signs that something was wrong the previous ...
bit.ly
May 5, 2025 at 2:52 PM
This weekend, our Chief Scientific Officer spoke with @foxnews.com.web.brid.gy to break down what people should know about glioblastoma following Michael Bolton's diagnosis, and how Carthera is advancing progress toward new breakthroughs in treatment delivery.
Full article: bit.ly/42ZTdM9
Full article: bit.ly/42ZTdM9
Learn more about how it is being applied in the treatment of recurrent #glioblastoma👇
www.sonobird.eu
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
www.sonobird.eu
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
SONOBIRD: a pivotal trial in recurrent glioblastoma
SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients u...
www.sonobird.eu
April 3, 2025 at 1:05 PM
Learn more about how it is being applied in the treatment of recurrent #glioblastoma👇
www.sonobird.eu
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
www.sonobird.eu
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
📺 Learn how our SonoCloud system works to disrupt the blood-brain barrier to enhance the delivery of therapeutic agents to brain tissues 🧠
www.youtube.com/watch?v=HhcO...
#SonoCloud #BBB #neurology #medtech #therapeuticultrasound
www.youtube.com/watch?v=HhcO...
#SonoCloud #BBB #neurology #medtech #therapeuticultrasound
Carthera's SonoCloud-9 System
YouTube video by Carthera
www.youtube.com
April 3, 2025 at 1:05 PM
📺 Learn how our SonoCloud system works to disrupt the blood-brain barrier to enhance the delivery of therapeutic agents to brain tissues 🧠
www.youtube.com/watch?v=HhcO...
#SonoCloud #BBB #neurology #medtech #therapeuticultrasound
www.youtube.com/watch?v=HhcO...
#SonoCloud #BBB #neurology #medtech #therapeuticultrasound
Our #SonoCloud device can be used to treat various brain diseases, such as #glioblastoma and #alzheimers
Learn more about how it works here 👇
carthera.eu/our-solutions/
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
Learn more about how it works here 👇
carthera.eu/our-solutions/
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
February 18, 2025 at 11:57 AM
Our #SonoCloud device can be used to treat various brain diseases, such as #glioblastoma and #alzheimers
Learn more about how it works here 👇
carthera.eu/our-solutions/
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.
Learn more about how it works here 👇
carthera.eu/our-solutions/
Products developed by Carthera are in clinical or preclinical evaluation and are not available for sale.